Additionally, recent research by Nguyen et al. (2014) discussed the role of inflammation and NF-κB activation in prostate cancer progression, highlighting the need for further exploration of inflammatory pathways to develop novel therapeutic strategie. Here, NFKB1 is linked to prostate carcinoma.